Literature DB >> 25962818

Rheumatoid Arthritis - Anti-TNF.

Khaldoun Chaabo1, Bruce Kirkham2.   

Abstract

This review will focus on the recent information and strategies now informing best use of TNF inhibitor therapy in RA. These issues include the role of TNFi therapy in early RA management, anti-drug antibodies in TNFi therapy, updates on safety and optimal dosage regimens in long term management.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Review; Rheumatoid arthritis; TNF; TNF inhibitors

Mesh：

Substances：

Year:  2015        PMID： 25962818     DOI： 10.1016/j.intimp.2015.04.051

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN： 1567-5769            Impact factor:   4.932


  11 in total

Review 1.  Use of etanercept to treat rheumatoid arthritis in an HIV-positive patient: a case-based review.

Authors:  Shen-Ju Liang; Quan-You Zheng; Yan-Long Yang; Yi Yang; Chong-Yang Liu
Journal:  Rheumatol Int       Date:  2017-03-02       Impact factor: 2.631

2.  Simvastatin Inhibits Toll-like Receptor 8 (TLR8) Signaling in Primary Human Monocytes and Spontaneous Tumor Necrosis Factor Production from Rheumatoid Synovial Membrane Cultures.

Authors:  Lisa Mullen; Jason Ferdjani; Sandra Sacre
Journal:  Mol Med       Date:  2015-08-24       Impact factor: 6.354

Review 3.  Effect of Anti-TNF Antibodies on Clinical Response in Rheumatoid Arthritis Patients: A Meta-Analysis.

Authors:  Chunxiao Wu; Shengxu Wang; Peifeng Xian; Lu Yang; Ying Chen; Xianjie Mo
Journal:  Biomed Res Int       Date:  2016-07-31       Impact factor: 3.411

4.  Nrf2 activation in osteoblasts suppresses osteoclastogenesis via inhibiting IL-6 expression.

Authors:  Tsuyoshi Narimiya; Hiroyuki Kanzaki; Yuki Yamaguchi; Satoshi Wada; Yuta Katsumata; Ken Tanaka; Hiroshi Tomonari
Journal:  Bone Rep       Date:  2019-11-01

5.  Shentong Zhuyu Decoction Inhibits Inflammatory Response, Migration, and Invasion and Promotes Apoptosis of Rheumatoid Arthritis Fibroblast-like Synoviocytes via the MAPK p38/PPARγ/CTGF Pathway.

Authors:  Ying Han; Jing Wang; Meng Jin; Lin Jia; Cuihuan Yan; Yali Wang
Journal:  Biomed Res Int       Date:  2021-01-15       Impact factor: 3.411

6.  Minimal change nephrotic syndrome due to certolizumab pegol, an anti-tumor necrosis factor-alpha monoclonal antibody for treatment of rheumatoid arthritis.

Authors:  Masafumi Sugiyama; Saki Okuda; Yasuaki Hirooka
Journal:  Rheumatol Adv Pract       Date:  2022-02-16

Review 7.  Toward Overcoming Treatment Failure in Rheumatoid Arthritis.

Authors:  Zhuqian Wang; Jie Huang; Duoli Xie; Dongyi He; Aiping Lu; Chao Liang
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

8.  Network pharmacology-based pharmacological mechanism prediction on Eucommia ulmoides against rheumatoid arthritis.

Authors:  Yonggan Ying; Zhaopeng Tang; Feng Niu; Taotao Xu; Chenjie Xia; Shuijun Zhang
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

9.  Matrine Exerts a Strong Anti-Arthritic Effect on Type II Collagen-Induced Arthritis in Rats by Inhibiting Inflammatory Responses.

Authors:  Jiang Pu; Fan-Fu Fang; Xiu-Qing Li; Zhi-Heng Shu; Yi-Ping Jiang; Ting Han; Wei Peng; Cheng-Jian Zheng
Journal:  Int J Mol Sci       Date:  2016-08-26       Impact factor: 5.923

10.  Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17A.

Authors:  Songmao Zheng; Fang Shen; Brian Jones; Damien Fink; Brian Geist; Ivo Nnane; Zhao Zhou; Jeff Hall; Ravi Malaviya; Tatiana Ort; Weirong Wang
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.